News
Allon's CEO featured in Vancouver Sun Special Report: The Future of Healthcare
Gordon McCauley, Allon Therapeutics' President and CEO, was featured on the front page of a special report in the Vancouver Sun newspaper on March 27, 2012 entitled "The Future of Healthcare." Click here to view the Report Continue reading
Posted in In the News
Allon's CEO interviewed on Vancouver radio
Gordon McCauley, Allon Therapeutics' President and CEO, was interviewed by Shannon Pearson on the AM 650 radio talk show "Venture Capital Radio." The interview aired on Tuesday March 20, 2012 at 6:00pm PST. Click here to watch the video Continue reading
Posted in In the News
Allon's orphan drug strategy highlighted in Business in Vancouver
Allon Therapeutics (TSX: NPC) was profiled in a Business in Vancouver article about "orphan drug" development. Gordon McCauley, Allon's President and CEO, was interviewed for the article. Click here to read the article Continue reading
Posted in In the News
Allon's CEO sets the record straight on McGeer's Alzheimer's research in the Vancouver Sun
Allon Therapeutics President and CEO, Gordon McCauley, sets the record straight on some of McGeer's comments in the Vancouver Sun article "Fighting Alzheimer's starts in the kitchen.” The article's author, Pamela Fayerman posted a follow-up column, including a letter from McCauley: "The 8 foods ... Continue reading
Posted in In the News
Allon advances Parkinsons disease program
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) announced today the completion of its first phase of work in a preclinical Parkinson’s disease (PD) model and advancement into the second phase of work. Both phases are funded by The Michael J. Fox Foundation (MJFF) for Parkinson’s Research and... Continue reading
Posted in News Releases